# BioIntervene, Inc. — Form D

BioIntervene, Inc. of BRISBANE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-06-23. The offering totals $5.6M, of which $5.6M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2021-06-23
- Form: D
- Accession: 0001771460-21-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.6M
- Amount sold: $5.6M
- Investors: 3
- Date of first sale: 2021-06-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-403933

## Issuer

- Name: BioIntervene, Inc.
- CIK: 0001771460
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: c/o MPM Capital, BRISBANE, CA, 94005
- Phone: 650-553-3300

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Gary J Bennett | Director | Brisbane, CA |
| David J Bredt | Director | Brisbane, CA |
| Ed Hurwitz | Director | San Diego, CA |
| Gary J Patou | Director | Brisbane, CA |
| Daniela J Salvemini | Director | Brisbane, CA |
| Simon J Tate | Director | Brisbane, CA |
| Gary J Bennett | Executive Officer | Brisbane, CA |
| Ed J Hurwitz | Director | San Diego, CA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2019-03-25](https://search.stillhousedata.com/formd/0001771460-19-000001) | D | $3.1M | $3.1M |

## More

- [CIK 1771460 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1771460&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001771460-21-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.